GNTA Genta Inc.

NSD
$1.00

Genta Inc. (GNTA) is expected to report earnings on July 22, 2026, before the market open.

Earnings Date
Jul 22
Wednesday · 7:05 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Genta Inc.

Genenta Science S.p.A. is a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for solid tumors, including the lead product candidate, Temferon(TM). Genenta Science S.p.A. is based in MILAN, Italy.

Sector

Healthcare

Industry

Biotechnology